首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝得健在肝动脉栓塞化疗时保肝作用的临床观察
引用本文:张银华,张世顺,董涛,刘志刚,赵存新.肝得健在肝动脉栓塞化疗时保肝作用的临床观察[J].临床肝胆病杂志,1999,15(1):52-53.
作者姓名:张银华  张世顺  董涛  刘志刚  赵存新
作者单位:262500,山东潍坊医学院附属青州医院
摘    要:对接受肝动脉栓塞化疗的33例原发性肝癌病人给予肝得健保肝,并设30例对照组。结果治疗组治疗前后肝功能无变化,对照组胆红素(BIL)3天升高,2周未降至正常;丙氨酸转氨酶(ALT)和门冬氨酸转氨酶(AST)3天、7天明显升高,2周降至正常;白蛋白(ALB)7天开始下降,2周回升,但未至正常水平。表明肝得健可防止正常肝细胞损害,保护肝功能,增强对栓塞化疗的耐受性。

关 键 词:肝得健  肝功能  原发性肝癌  肝动脉栓塞化疗
修稿时间:1998年2月26日

A clinical study of protecting hepatic function of Essential in the hepatic arterial chemoembolization
Zhangyinhua,ZhangShishun,Dong Tao,etalAffillatedqingzhouhospitalweifangmedicalcollege.A clinical study of protecting hepatic function of Essential in the hepatic arterial chemoembolization[J].Chinese Journal of Clinical Hepatology,1999,15(1):52-53.
Authors:Zhangyinhua  ZhangShishun  Dong Tao  etalAffillatedqingzhouhospitalweifangmedicalcollege
Institution:Zhangyinhua,ZhangShishun,Dong Tao,etalAffillatedqingzhouhospitalweifangmedicalcollege262500
Abstract:GivetheEssentialeto33patientswithprimaryhepatocelluarcarcinomawereinthehepaticarterialchemoembolizationforprotectionofhepaticfunctionandhaveacontrolgroupatthesametimeTheresultsshowedthataftertreatmenttherewasnodifferenceinthehepaticfunctionoftreatmentgroupWhiletheBILofthecontrolgroupraised3dayslaterafterhepaticarterialchemoembolizationanddidntreturntothenormallevelafter2weeks;theALTandASTraisedmarkedlyinthe3or7daysandreturntothenormallevelafter2weeks;TheALBbegantofallinthe7daysandraisefromthe14days,butdidntreturntothenormallevelTheresultsindicatedthatEssenttalusedinhepaticarterialchemoembolizationcanprotecthepaticcellfrombeingdistroied;protectthefunctionofliverandreducethesideeffects
Keywords:EssentialHepaticfunctionPrimaryhepatocellularcarcinomaHepaticarterialchemoembolization
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号